COVID-19 During Pregnancy Linked to Rise in Congenital Heart Disease in Newborns

Medical News: A new study conducted by researchers from several institutions in China and the United States has shed light on the potential link between maternal COVID-19 infection during pregnancy and the increased incidence of congenital heart disease (CHD) in newborns. The study, led by experts from Shanxi Province Integrated Traditional and Western Medicine Hospital-China, Children’s Hospital of Shanxi Province-China, and Stanford University School of Medicine-USA, explored the effects of maternal COVID-19 on fetal heart development, highlighting the need for vigilant prenatal care during the ongoing pandemic.


COVID-19 During Pregnancy Linked to Rise in Congenital Heart Disease in Newborns

Key Findings of the Study
The research focuses on a comparison between pregnant women who contracted COVID-19 and those who did not. Data was collected on maternal characteristics, pregnancy-related complications, and the outcomes of their newborns. One of the most significant findings was the higher prevalence of cardiac abnormalities in babies born to mothers who were infected with COVID-19 during pregnancy. This Medical News report dives into the details of these findings and the implications they have for pregnant women and newborns during the pandemic.
 
This retrospective study included two groups: one group of women who tested positive for COVID-19 during pregnancy and a control group of women without COVID-19 infection. The study aimed to explore the basic maternal characteristics, pregnancy complications, and outcomes of their newborns, with a particular focus on congenital heart defects.
 
The Link Between COVID-19 and Congenital Heart Defects
The study found that although maternal characteristics such as age, BMI, and pregnancy complications like diabetes and preeclampsia were similar between the two groups, there was a significant difference in the prevalence of cardiac abnormalities in newborns. Cardiac ultrasound detected abnormalities in 10.08% of babies born to mothers with COVID-19, compared to only 4.13% in the control group. This sharp increase points to a possible connection between maternal infection and heart development issues in fetuses.
 
Further analysis revealed that most of these abnormalities occurred in mothers who contracted COVID-19 in the early stages of pregnancy, particularly before the 8th week. This early infection seemed to increase the risk of conditions like atrial septal defect (ASD), ventricular septal defect (VSD), and patent ductus arteriosus (PDA). These heart conditions, if left undetected, can cause serious health issues for children later in life.
 
The Annual Rise in Congenital Heart Disease
One of the study’s most revealing findings was the significant rise in the annual incidence of CHD in newborns during the COVID-19 pandemic. From 2020 to 2023, the incidence of CHD increased steadily, with the highest rate recorded in 2023 at 5.46%. This is a notable jump from previous years, where the incidence was 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022.&l t;br />  
Researchers believe that this surge in CHD cases could be linked to the inflammatory response triggered by the COVID-19 virus. The inflammatory environment created by the infection may interfere with the normal development of the fetal heart, particularly during the critical early stages of pregnancy. Moreover, reduced access to routine prenatal care during the pandemic could have contributed to the higher incidence of undetected heart abnormalities.
 
How COVID-19 Affects Fetal Development
This article underscores that COVID-19 may affect fetal heart development through both direct and indirect mechanisms. The virus enters cells through angiotensin-converting enzyme 2 (ACE2) receptors, which are present in fetal tissues, including the heart. By entering fetal tissues, the virus may interfere with the normal development of the heart, leading to structural abnormalities. This disruption may be particularly harmful during the first eight weeks of gestation, when the heart is forming.
 
In addition to direct viral effects, maternal inflammation caused by COVID-19 can also impact fetal development. Inflammatory cytokines produced by the mother’s immune response can cross the placenta and affect the developing fetus. Inflammation has been known to cause complications in pregnancies, leading to conditions like preterm birth, intrauterine growth restriction, and birth defects, including CHD.
 
The Importance of Early Detection and Vigilant Care
The findings of this study highlight the critical need for early detection and vigilant prenatal care during pregnancy, especially during pandemics like COVID-19. Routine fetal echocardiography, particularly for mothers who contract COVID-19, is essential to detect any potential cardiac issues early on. Early detection allows for timely medical intervention, which can improve outcomes for children born with congenital heart defects.
 
Given the potential long-term health implications of congenital heart disease, the study recommends increased monitoring of newborns whose mothers contracted COVID-19. This is especially important in cases where the mother was infected in the first trimester, as the risk for heart abnormalities seems to be highest during this critical period of heart development.
 
Broader Implications for Public Health
The study also points to broader public health implications. As the world continues to face waves of COVID-19 and its variants, pregnant women remain a vulnerable population. The increased incidence of CHD during the pandemic suggests that there may be lasting impacts on maternal and child health, even after the pandemic subsides.
 
The researchers emphasize that their findings call for further research into the mechanisms behind COVID-19-related congenital anomalies. There is still much to learn about how COVID-19 affects fetal development and the best ways to protect pregnant women and their babies.
 
The healthcare system’s ability to provide timely prenatal care during pandemics will also need to be addressed. The disruptions in healthcare delivery, especially during the height of the pandemic, may have contributed to the rise in undiagnosed congenital heart defects. Strengthening healthcare systems and ensuring access to routine prenatal care during public health crises is crucial for preventing adverse outcomes like CHD.
 
Conclusion
In conclusion, this study adds to the growing body of research highlighting the potential impact of maternal COVID-19 infection on fetal health. The significantly higher incidence of congenital heart defects in babies born to COVID-19-positive mothers points to the need for heightened awareness and prenatal care. As the pandemic continues, healthcare providers must prioritize the monitoring and early detection of heart abnormalities in newborns to ensure the best possible outcomes. Further research is needed to confirm these findings and to explore the exact mechanisms by which COVID-19 affects fetal heart development.
 
The study findings were published in the peer-reviewed journal: Scientific Reports.
https://link.springer.com/article/10.1038/s41598-024-76690-6
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-pediatricians-warn-that-covid-19-can-cause-gastric-perforations-in-new-borns
 
https://www.thailandmedical.news/news/covid-19-news-study-shows-that-exposure-to-sars-cov-2-during-pregnancy-results-in-newborns-developing-epigenetic-changes
 
https://www.thailandmedical.news/news/study-shows-disruptions-in-lipid-metabolism-in-covid-19-infections-during-pregnancy-will-affect-newborn-health
 
https://www.thailandmedical.news/news/covid-19-infection-during-pregnancy-increases-risk-of-adverse-maternal,-fetal,-and-newborn-outcomes-and-increases-risk-of-death